This is a profile image of Dan Tinkoff

Dan Tinkoff

Senior PartnerNew Jersey

Global leader of QuantumBlack, AI by McKinsey; leverages in-depth industry knowledge and AI expertise to help life-science companies with strategy and business transformations

Dan is a senior partner in McKinsey’s New Jersey office and leads QuantumBlack, AI by McKinsey, globally and in North America. He leverages his data and AI expertise and extensive industry knowledge to advise leaders and chief digital and AI officers of life-science businesses on their strategies and operating models. He also works extensively with organizations on transforming and innovating their capabilities for today’s dynamic healthcare and technology landscape.

Examples of his recent client work include:

  • helping a leading pharmaceutical company envision and design a tech-enabled direct-to-consumer channel for medication dispensing, telehealth, and assistance across the continuum of care
  • assisting a leading eye care company in building a differentiated B2B2C e-commerce platform to create more value for eye care professionals and their patients
  • supporting a leading healthcare company’s program to identify new business models to generate revenue from its data assets
  • helping a major pharmaceutical company develop an enterprise advanced analytics strategy, operating model, and implementation plan to drive a more than 10 percent incremental earnings increase from prioritized analytics use cases over three years
  • envisioning the AI-enabled future of a leading veterinary diagnostics and software company

Published work

Reimagining life science enterprises with agentic AI,” McKinsey & Company, September 2025

The most important part of the technology puzzle: People,” McKinsey & Company, December 2024

Rewired pharma companies will win in the digital age,” McKinsey & Company, June 2023

Top ten observations from 2022 in life sciences digital and analytics,” McKinsey & Company, January 2023

How pharma can accelerate business impact from advanced analytics,” McKinsey & Company, January 2018

Innovating at the speed of the 21st century in pharmaceuticals,” McKinsey & Company, October 2017

Education

Harvard University
BS, biomedical engineering